NEW YORK, Oct. 4, 2013 /PRNewswire/ -- Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Greenway Medical Technologies, Inc. ("Greenway" or the "Company") (NYSE: GWAY) for potential breaches of fiduciary duties in connection with their conduct related to the sale of the Company to Vista Equity Partners in a deal valued at approximately $644 million. Under the terms of the proposed transaction, Greenway's stockholders will receive $20.35 for each share of Greenway common stock they own.
Request more information now by clicking here: www.faruqilaw.com/GWAY. There is no cost or obligation to you.
The investigation focuses on whether Greenway's Board of Directors breached their fiduciary duties to the Company's stockholders by failing to conduct an adequate and fair sales process prior to agreeing to this proposed transaction, whether and by how much this proposed transaction undervalues the Company to the detriment of Greenway's shareholders.Faruqi & Faruqi, LLP is a national law firm which represents investors and individuals in class action litigation. The firm is focused on providing exemplary legal services in complex litigation in the areas of securities, shareholder, antitrust and consumer litigation, throughout all phases of litigation. The firm has an experienced trial team which has achieved significant victories on behalf of the firm's clients. If you own common stock in Greenway and wish to obtain additional information and protect your investments free of charge, please visit us at www.faruqilaw.com/GWAY or contact Juan E. Monteverde, Esq. either via e-mail at firstname.lastname@example.org or by telephone at (877) 247-4292 or (212) 983-9330. Contact:
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts